| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.0B | $12.4B | $10.1B | $8.6B | $7.7B | $5.9B | $1.4B | $1.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.9B | $1.1B | $1.1B | $0.8B | $0.5B | $0.5B | $0.1B | $0.1B |
| EPS (Basic) | $10.97 | $14.17 | $13.88 | $10.60 | $5.75 | $5.96 | $1.57 | $1.40 |
| EPS (Diluted) | $10.92 | $14.03 | $13.69 | $10.40 | $5.63 | $5.86 | $1.53 | $1.36 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.5B | $13.3B | $10.4B | $9.5B | $8.0B | $6.5B | $5.9B | $5.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.0B | $1.0B | $0.5B | $0.8B | $0.5B | $0.8B | $0.6B | $0.5B |
| Total Liabilities | $13.1B | $10.4B | $8.3B | $7.3B | $6.3B | $5.2B | $4.9B | $4.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.3B | $2.9B | $2.1B | $2.2B | $1.7B | $1.3B | $1.0B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.4B | $0.3B | $0.5B | $1.9B | $0.5B | $0.8B | $0.6B | $0.6B |
| Investing Cash Flow | $-2.4B | $-1.6B | $-0.9B | $-0.4B | $-0.5B | $-0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.6B | $0.6B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $3.2B | $1.4B | $-0.2B | $-0.5B | $0.3B | $-0.3B | $-0.5B | $-0.5B |